ArticleDrug design, development and therapy2018

Efficacy of intra-meibomian gland injection of the anti-VEGF agent bevacizumab for the treatment of meibomian gland dysfunction with lid-margin vascularity.

Xiaodan Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.